Resources

Mistral currently enrolling clinical trials:

TRIBUTE Study - Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study

MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study

MATTERS II - Mistral Percutaneous Tricuspid Valve Repair FIM Study

MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study

Publications:

First-in-Human Transcatheter Tricuspid Valve Repair - 30-Day Follow-Up Experience With the Mistral Device. David Planer, MD, Ronen Beeri, MD and Haim D. Danenberg, MD, Hadassah Medical Center, Israel. Published: JACC Cardiovascular Intervention, September 2020

The Mistral Device for Transcatheter Tricuspid Valve Repair: A Bouquet in the Armory to Treat Tricuspid Regurgitation. Editorial comment, Holger Thiele and Philipp Lurz. Published: JACC Cardiovascular Intervention, September 2020.

First Short-Term Follow-Up of Mistral Tricuspid Valve Repair Finds Significant Improvement in Severe TR. Natalie Morrison, CRTonline.org, September 2020.

Conferences:

ASE 2021 (PC-27)

The Mistral Chordal TV Repair Device Efficiently Reduces TR, Improves RV Systolic Function and Induces RV Reverse Remodeling: Echocardiographic Analysis. Prof. Ronen Beeri, Israel.

EuroPCR 2021 ePoster:

Mistral chordal TV Repair improves TR, RV function and remodeling. Prof. Ronen Beeri, Israel.

ICI 2020 ePoster:

Mistral Tricuspid Regurgitation Echocardiography CoreLab Analysis

Prof. Yan Topilsky, Israel.

CRT 2020 Conference presentation slides: Prof. Danenberg, Israel.

TVT 2019 Conference presentation slides: Dr. Planer, Israel.

Mistral Animations:

Animation - Mistral Transcatheter Tricuspid Valve Repair System

Animation - Mistral Transcatheter Mitral Valve Repair System

Mistral Implant Image

Mistral Implant GIF

Mistral Implant vs Euro Coin